Title:
PHARMACEUTICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2023/238952
Kind Code:
A9
Abstract:
The present invention provides a pharmaceutical composition containing a pharmaceutically acceptable salt of (2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetic acid (compound B) with good storage stability. The present invention is a pharmaceutical composition containing the following components: (A) a pharmaceutically acceptable salt of (2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetic acid; (B) a buffering agent 1 having a buffering capacity in a basic region, and a buffering agent 2 having a buffering capacity in a neutral region, or a buffering agent 3 having a buffering capacity in a basic region to a neutral region; and (C) a pH-adjusting agent.
Inventors:
FUCHIKAMI CHIAKI (JP)
MORIUCHI MAI (JP)
KATO DAIKI (JP)
MORIUCHI MAI (JP)
KATO DAIKI (JP)
Application Number:
PCT/JP2023/021625
Publication Date:
February 01, 2024
Filing Date:
June 09, 2023
Export Citation:
Assignee:
NIPPON SHINYAKU CO LTD (JP)
International Classes:
A61K31/4965; A61K9/19; A61K47/02; A61K47/12; A61K47/18; A61P9/12
Attorney, Agent or Firm:
SAEGUSA & PARTNERS (JP)
Download PDF:
Previous Patent: RESIN COMPOSITION FOR MOLDING AND ELECTRONIC COMPONENT DEVICE
Next Patent: AUTHENTICATION DEVICE AND AUTHENTICATION METHOD
Next Patent: AUTHENTICATION DEVICE AND AUTHENTICATION METHOD